Clinical trial

A Study of PER-001 in Participants With Diabetic Retinopathy

NCT06003751

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-08-05

PhasePHASE2

Study timeline

Study start (actual)2023-08-05Date precision: day

Registry last updated2026-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyunresolved

Interventions

PER-001 Intravitreal Implant - Low DoseDRUG

PER-001 Intravitreal Implant - High DoseDRUG

PER-001 Intravitreal Implant - ShamDRUG

Sponsors & collaborators

Perfuse Therapeutics, Inc.lead sponsor

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06003751 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.